[1]. Garcia-Laorden MI, Lorente JA, Flores C, et al. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med. 2017;5(14):283.
[2]. Wong AP, Keating A, Waddell TK. Airway regeneration: the role of the Clara cell secretory protein and the cells that express it. Cytotherapy. 2009;11(6):676-87.
[3]. Boers JE, Ambergen AW, Thunnissen FB. Number and proliferation of basal and parabasal cells in normal human airway epithelium. Am J Respir Crit Care Med. 1998;157(6 Pt 1):2000-6.
[4]. Broeckaert F, Clippe A, Knoops B, et al. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci. 2000;923:68-77.
[5]. Lesur O, Langevin S, Berthiaume Y, et al. Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med. 2006;32(8):1167-74.
[6]. Determann RM, Millo JL, Waddy S, et al. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study. BMC Pulm Med. 2009;9:49.
[7]. Wutzler S, Backhaus L, Henrich D, et al. Clara cell protein 16: A biomarker for detecting secondary respiratory complications in patients with multiple injuries. J Trauma Acute Care Surg. 2012;73(4):838-42.
[8]. Kropski JA, Fremont RD, Calfee CS, et al. Clara Cell Protein (CC16), a Marker of Lung Epithelial Injury, Is Decreased in Plasma and Pulmonary Edema Fluid From Patients With Acute Lung Injury. Chest. 2009;135(6):1440-7.
[9]. Ware LB, Koyama T, Zhao Z, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17(5):R253.
[10]. Lin J, Zhang W. Diagnostic and prognostic values of Club cell protein 16 (CC16) in critical care patients with acute respiratory distress syndrome. J Clin Lab Anal. 2018;32(2):e22262.
[11]. Force ADT, Ranieri VM, Rubenfeld GD, et al.Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-33.
[12]. Levin A, Stevens PE, Bilous RW, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013;3(1):1-150.
[13]. Hantson P, Bernard A, Hermans C. Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injury. Clin Toxicol (Phila). 2008;46(3):230-8.
[14]. Provost EB, Chaumont A, Kicinski M, et al. Serum levels of club cell secretory protein (Clara) and short- and long-term exposure to particulate air pollution in adolescents. Environment international. 2014;68:66-70.
[15]. St Helen G HN, Balmes JR, Hall DB, et al. Utility of urinary Clara cell protein (CC16) to demonstrate increased lung epithelial permeability in non-smokers exposed to outdoor secondhand smoke. Journal of Exposure Science & Environmental Epidemiology. 2013;23(2).
[16]. Ishida S, Hashimoto I, Seike T, et al. Serum albumin levels correlate with inflammation rather than nutrition supply in burns patients: a retrospective study. J Med Invest. 2014;61(3-4):361-8.
[17]. Amsellem S, Gburek J, Hamard G, et al. Cubilin is essential for albumin reabsorption in the renal proximal tubule. J Am Soc Nephrol. 2010;21(11):1859-67.
[18]. Andersson L, Preda I, Hahn-Zoric M, et al. Urinary proteins in children with urinary tract infection. Pediatr Nephrol. 2009;24(8):1533-8.
[19]. Hantson P, Weynand B, Doyle I, et al. Pneumoproteins as markers of paraquat lung injury: a clinical case. J Forensic Leg Med. 2008;15(1):48-52.
[20]. Mekontso Dessap A, Ware LB, Bagshaw SM. How could biomarkers of ARDS and AKI drive clinical strategies? Intensive care medicine. 2016;42(5):800-2.
[21]. Potter JM, Simpson AJ, Kerrigan J, et al. The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT-proBNP concentrations in a hospital and community outpatient population. Clinical Biochemistry. 2017;50(15):813-5.
[22]. Jensen JS, Itenov TS, Thormar KM, et al. Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial. Ann Intensive Care. 2016;6(1):114.
[23]. Yoshikawa S, Miyahara T, Reynolds SD, et al. Clara cell secretory protein and phospholipase A2 activity modulate acute ventilator-induced lung injury in mice. J Appl Physiol. 2005;98(4):1264-71.
[24]. Johansson S, Wennergren G, Aberg N, et al. Clara cell 16-kd protein downregulates T(H)2 differentiation of human naive neonatal T cells. J Allergy Clin Immunol. 2007;120(2):308-14.
[25]. Pang M, Wang H, Bai JZ, et al. Recombinant rat CC16 protein inhibits LPS-induced MMP-9 expression via NF-kappaB pathway in rat tracheal epithelial cells. Exp Biol Med (Maywood). 2015;240(10):1266-78.
[26]. Pang M, Yuan Y, Wang D, et al. Recombinant CC16 protein inhibits the production of pro-inflammatory cytokines via NF-κB and p38 MAPK pathways in LPS-activated RAW264.7 macrophages. Acta biochimica et biophysica Sinica. 2017;49(5):435-43.
[27]. Pang M, Liu H-Y, Li T, et al. Recombinant club cell protein 16 (CC16) ameliorates cigarette smoke‑induced lung inflammation in a murine disease model of COPD. Molecular medicine reports. 2018;18(2):2198-206.
[28]. Lesur O, Hermans C, Chalifour JF, et al. Mechanical ventilation-induced pneumoprotein CC-16 vascular transfer in rats: effect of KGF pretreatment. Am J Physiol Lung Cell Mol Physiol. 2003;284(2):L410-9.
[29]. Sarafidis K, Stathopoulou T, Agakidou E, et al. Comparable effect of conventional ventilation versus early high-frequency oscillation on serum CC16 and IL-6 levels in preterm neonates. Journal of Perinatology. 2011;31(2):104-11.